Clarfeld Financial Advisors’s Pfizer PFE Stock Holding History

Clarfeld Financial Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$131K	Buy	+3,163	New	+$131K	0.11%	61

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Clarfeld Financial Advisors's PFE Position: Q4 2018 in Review

Clarfeld Financial Advisors opened a new position in Pfizer (PFE) in Q4 2018: 3,163 shares worth $131K. The stake represents 0.11% of the portfolio and ranks #61 among its holdings.

2,404 funds tracked by Wall St. Rank hold PFE as of Q4 2018.

Clarfeld Financial Advisors held 3,163 shares of Pfizer worth $131K as of Q4 2018.
Pfizer was a new Clarfeld Financial Advisors position in Q4 2018.
Pfizer made up 0.11% of Clarfeld Financial Advisors's portfolio in Q4 2018, its #61 holding.
2,404 funds tracked by Wall St. Rank held Pfizer as of Q4 2018.

Based on Clarfeld Financial Advisors's 13F filing for Q4 2018, filed 15 Feb 2019.